That means Berkshire now owns about 16.5% of DaVita, but it has agreed not to buy more than 25% of the Denver-based company unless, both companies agree.
Denver-based DaVita runs nearly 2,000 outpatient dialysis clinics.DaVita said last week that its operating costs increased during the quarter, and it said the Justice Department has been investigating its business practices. The stock was trading above $56, but quickly lost more than $2 a share after DaVita's earnings report. That's when Berkshire started buying.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts